Investigative Journalism

BioPharm Insight’s global team of investigative journalists interview key opinion leaders and industry experts in the biopharmaceutical space. Subscribers receive real-time breaking news as well as predictive and competitive intelligence 3-12 months ahead of industry catalysts.

The editorial team covers a wide array of topics within the biopharmaceutical space including but not limited to:


Expected Clinical Results
Upcoming Drug Approvals
Drug Pricing and Uptake
Regulatory and Reimbursement Trends
CRO Opportunities
Potential M&As, Financing and IPOs
Licensing and Partnership Opportunities

Check out their recent articles


Catalyst Monitor
Indication Specific
Clinical Activity
Adverse Events
CRO & CMO Intelligence & Activity
VC Intelligence & Activity

Check out their recent reports

Unmatched Access to Key Sources

BioPharm Insight journalists have unparalleled access to a global network of key opinion leaders and industry experts. Through exclusive interviews with relevant and active clinical trial investigators, physicians, researchers, consultants, lawyers, and C-level executives, the editorial team is able to give our subscribers unique insight 3-12 months ahead of industry catalysts.

Unbiased Coverage

BioPharm Insight's content is independent from external influences with an ad-free web platform and separation between its editorial team and commercial side of the business. News sources are never compensated for their interviews and BioPharm Insight and editors verify facts and source credentials to ensure each article is 100% objective.